| Year |
Citation |
Score |
| 2023 |
Fan J, Li S, Zhang Y, Zheng J, Wang D, Liao Y, Cui Z, Zhao D, Barouch DH, Yu J. Early Emerging SARS-CoV-2 Spike Mutants Are Diversified in Virologic Properties but Elicit Compromised Antibody Responses. Viruses. 15. PMID 38140642 DOI: 10.3390/v15122401 |
0.752 |
|
| 2023 |
Vidal SJ, Sellers D, Yu J, Wakabayashi S, Sixsmith J, Aid M, Barrett J, Stevens SF, Liu X, Li W, Plumlee CR, Urdahl KB, Martinot AJ, Barouch DH. Attenuated vaccine protection in a low-dose murine challenge model. Iscience. 26: 106963. PMID 37378347 DOI: 10.1016/j.isci.2023.106963 |
0.548 |
|
| 2023 |
Solforosi L, Costes LMM, Tolboom JTBM, McMahan K, Anioke T, Hope D, Murdza T, Sciacca M, Bouffard E, Barrett J, Wu C, Hachmann N, Miller J, Yu J, He X, et al. Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques. Nature Communications. 14: 1944. PMID 37029141 DOI: 10.1038/s41467-023-37715-2 |
0.601 |
|
| 2023 |
Yu J, Thomas PV, Sciacca M, Wu C, Liu J, He X, Miller J, Hachmann NP, Surve N, McMahan K, Jacob-Dolan C, Powers O, Hall K, Barrett J, Hope D, et al. Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques. Cell Reports. Medicine. 101018. PMID 37023746 DOI: 10.1016/j.xcrm.2023.101018 |
0.612 |
|
| 2023 |
Nanishi E, Borriello F, Seo HS, O'Meara TR, McGrath ME, Saito Y, Chen J, Diray-Arce J, Song K, Xu AZ, Barman S, Menon M, Dong D, Caradonna TM, Feldman J, ... ... Yu J, et al. Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice. Npj Vaccines. 8: 30. PMID 36869134 DOI: 10.1038/s41541-023-00634-w |
0.395 |
|
| 2023 |
Jacob-Dolan C, Yu J, McMahan K, Giffin V, Chandrashekar A, Martinot AJ, Anioke T, Powers OC, Hall K, Hope D, Miller J, Hachmann NP, Chung B, Gardner S, Sellers D, et al. Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques. Npj Vaccines. 8: 23. PMID 36823160 DOI: 10.1038/s41541-023-00622-0 |
0.607 |
|
| 2023 |
Nanishi E, Borriello F, Seo HS, O'Meara TR, McGrath ME, Saito Y, Chen J, Diray-Arce J, Song K, Xu AZ, Barman S, Menon M, Dong D, Caradonna TM, Feldman J, ... ... Yu J, et al. Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice. Npj Vaccines. 8: 18. PMID 36788219 DOI: 10.1038/s41541-023-00610-4 |
0.479 |
|
| 2022 |
Cooper A, Sidaway A, Chandrashekar A, Latta E, Chakraborty K, Yu J, McMahan K, Giffin V, Manickam C, Kroll K, Mosher M, Reeves RK, Gam R, Arthofer E, Choudhry M, et al. A genetically engineered, stem-cell-derived cellular vaccine. Cell Reports. Medicine. 100843. PMID 36480934 DOI: 10.1016/j.xcrm.2022.100843 |
0.62 |
|
| 2022 |
Yu J, Thomas PV, McMahan K, Jacob-Dolan C, Liu J, He X, Hope D, Martinez EJ, Chen WH, Sciacca M, Hachmann NP, Lifton M, Miller J, Powers OC, Hall K, et al. Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN. Science Advances. 8: eade4433. PMID 36417525 DOI: 10.1126/sciadv.ade4433 |
0.59 |
|
| 2022 |
Nilles EJ, Paulino CT, de St Aubin M, Restrepo AC, Mayfield H, Dumas D, Finch E, Garnier S, Etienne MC, Iselin L, Duke W, Jarolim P, Oasan T, Yu J, Wan H, et al. SARS-CoV-2 seroprevalence, cumulative infections, and immunity to symptomatic infection - A multistage national household survey and modelling study, Dominican Republic, June-October 2021. Lancet Regional Health. Americas. 16: 100390. PMID 36408529 DOI: 10.1016/j.lana.2022.100390 |
0.554 |
|
| 2022 |
Dagotto G, Ventura JD, Martinez DR, Anioke T, Chung BS, Siamatu M, Barrett J, Miller J, Schäfer A, Yu J, Tostanoski LH, Wagh K, Baric RS, Korber B, Barouch DH. Immunogenicity and protective efficacy of a rhesus adenoviral vaccine targeting conserved COVID-19 replication transcription complex. Npj Vaccines. 7: 125. PMID 36302778 DOI: 10.1038/s41541-022-00553-2 |
0.595 |
|
| 2022 |
Tan CS, Collier AY, Yu J, Liu J, Chandrashekar A, McMahan K, Jacob-Dolan C, He X, Roy V, Hauser BM, Munt JE, Mallory ML, Mattocks M, Powers JM, Meganck RM, et al. Durability of Heterologous and Homologous COVID-19 Vaccine Boosts. Jama Network Open. 5: e2226335. PMID 35947380 DOI: 10.1001/jamanetworkopen.2022.26335 |
0.563 |
|
| 2022 |
Liu J, Yu J, McMahan K, Jacob-Dolan C, He X, Giffin V, Wu C, Sciacca M, Powers O, Nampanya F, Miller J, Lifton M, Hope D, Hall K, Hachmann NP, et al. CD8 T Cells Contribute to Vaccine Protection Against SARS-CoV-2 in Macaques. Science Immunology. eabq7647. PMID 35943359 DOI: 10.1126/sciimmunol.abq7647 |
0.631 |
|
| 2022 |
Nanishi E, McGrath ME, O'Meara TR, Barman S, Yu J, Wan H, Dillen CA, Menon M, Seo HS, Song K, Xu AZ, Sebastian L, Brook B, Bosco AN, Borriello F, et al. mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant. Communications Biology. 5: 790. PMID 35933439 DOI: 10.1038/s42003-022-03765-3 |
0.573 |
|
| 2022 |
Gebre MS, Rauch S, Roth N, Gergen J, Yu J, Liu X, Cole AC, Mueller SO, Petsch B, Barouch DH. mRNA vaccines induce rapid antibody responses in mice. Npj Vaccines. 7: 88. PMID 35915094 DOI: 10.1038/s41541-022-00511-y |
0.608 |
|
| 2022 |
Hartwell BL, Melo MB, Xiao P, Lemnios AA, Li N, Chang JYH, Yu J, Gebre MS, Chang A, Maiorino L, Carter C, Moyer TJ, Dalvie NC, Rodriguez-Aponte SA, Rodrigues KA, et al. Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunity. Science Translational Medicine. 14: eabn1413. PMID 35857825 DOI: 10.1126/scitranslmed.abn1413 |
0.61 |
|
| 2022 |
Nkolola JP, Yu J, Wan H, Chang A, McMahan K, Anioke T, Jacob-Dolan C, Powers O, Ye T, Chandrashekar A, Sellers D, Barrett J, Loo YM, Esser MT, Carnahan RH, et al. A bivalent SARS-CoV-2 monoclonal antibody combination does not impact the immunogenicity of a vector-based COVID-19 vaccine in macaques. Science Translational Medicine. eabo6160. PMID 35857623 DOI: 10.1126/scitranslmed.abo6160 |
0.608 |
|
| 2022 |
Hachmann NP, Miller J, Collier AY, Ventura JD, Yu J, Rowe M, Bondzie EA, Powers O, Surve N, Hall K, Barouch DH. Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5. The New England Journal of Medicine. PMID 35731894 DOI: 10.1056/NEJMc2206576 |
0.393 |
|
| 2022 |
Piedra-Mora C, Robinson SR, Tostanoski LH, Dayao DAE, Chandrashekar A, Bauer K, Wrijil L, Ducat S, Hayes T, Yu J, Bondzie EA, McMahan K, Sellers D, Giffin V, Hope D, et al. Reduced SARS-CoV-2 disease outcomes in Syrian hamsters receiving immune sera: Quantitative image analysis in pathologic assessments. Veterinary Pathology. 3009858221095794. PMID 35521761 DOI: 10.1177/03009858221095794 |
0.48 |
|
| 2022 |
Zhu DY, Gorman MJ, Yuan D, Yu J, Mercado NB, McMahan K, Borducchi EN, Lifton M, Liu J, Nampanya F, Patel S, Peter L, Tostanoski LH, Pessaint L, Van Ry A, et al. Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates. Plos Biology. 20: e3001609. PMID 35512013 DOI: 10.1371/journal.pbio.3001609 |
0.614 |
|
| 2022 |
Chandrashekar A, Yu J, McMahan K, Jacob-Dolan C, Liu J, He X, Hope D, Anioke T, Barrett J, Chung B, Hachmann NP, Lifton M, Miller J, Powers O, Sciacca M, et al. Vaccine protection against the SARS-CoV-2 Omicron variant in macaques. Cell. PMID 35427477 DOI: 10.1016/j.cell.2022.03.024 |
0.625 |
|
| 2022 |
Yu J, Collier AY, Rowe M, Mardas F, Ventura JD, Wan H, Miller J, Powers O, Chung B, Siamatu M, Hachmann NP, Surve N, Nampanya F, Chandrashekar A, Barouch DH. Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants. The New England Journal of Medicine. PMID 35294809 DOI: 10.1056/NEJMc2201849 |
0.398 |
|
| 2022 |
Dalvie NC, Tostanoski LH, Rodriguez-Aponte SA, Kaur K, Bajoria S, Kumru OS, Martinot AJ, Chandrashekar A, McMahan K, Mercado NB, Yu J, Chang A, Giffin VM, Nampanya F, Patel S, et al. SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaques. Science Advances. 8: eabl6015. PMID 35294244 DOI: 10.1126/sciadv.abl6015 |
0.608 |
|
| 2022 |
Collier AY, Brown CM, McMahan KA, Yu J, Liu J, Jacob-Dolan C, Chandrashekar A, Tierney D, Ansel JL, Rowe M, Sellers D, Ahmad K, Aguayo R, Anioke T, Gardner S, et al. Characterization of immune responses in fully vaccinated individuals following breakthrough infection with the SARS-CoV-2 delta variant. Science Translational Medicine. eabn6150. PMID 35258323 DOI: 10.1126/scitranslmed.abn6150 |
0.633 |
|
| 2022 |
Chang A, Yu J. Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19. Viruses. 14. PMID 35215973 DOI: 10.3390/v14020380 |
0.425 |
|
| 2022 |
Mahrokhian SH, Tostanoski LH, Jacob-Dolan C, Zahn RC, Wegmann F, McMahan K, Yu J, Gebre MS, Bondzie EA, Wan H, Powers O, Ye T, Barrett J, Schuitemaker H, Barouch DH. Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice. Npj Vaccines. 7: 23. PMID 35197477 DOI: 10.1038/s41541-022-00454-4 |
0.573 |
|
| 2022 |
He X, Aid M, Chandrashekar A, Yu J, McMahan K, Wegmann F, Jacob-Dolan C, Maron JS, Atyeo C, Wan H, Sellers D, Liu J, Lifton M, Gardner S, A Bondzie E, et al. A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaques. Science Translational Medicine. eabm4996. PMID 35191769 DOI: 10.1126/scitranslmed.abm4996 |
0.549 |
|
| 2022 |
Yu J, Collier AY, Rowe M, Mardas F, Ventura JD, Wan H, Miller J, Powers O, Chung B, Siamatu M, Hachmann NP, Surve N, Nampanya F, Chandrashekar A, Barouch DH. Comparable Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants. Medrxiv : the Preprint Server For Health Sciences. PMID 35169817 DOI: 10.1101/2022.02.06.22270533 |
0.587 |
|
| 2022 |
Chandrashekar A, Yu J, McMahan K, Jacob-Dolan C, Liu J, He X, Hope D, Anioke T, Barrett J, Chung B, Hachmann NP, Lifton M, Miller J, Powers O, Sciacca M, et al. Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques. Biorxiv : the Preprint Server For Biology. PMID 35169798 DOI: 10.1101/2022.02.06.479285 |
0.587 |
|
| 2022 |
Cobb RR, Nkolola J, Gilchuk P, Chandrashekar A, Yu J, House RV, Earnhart CG, Dorsey NM, Hopkins SA, Snow DM, Chen RE, VanBlargan LA, Hechenblaickner M, Hoppe B, Collins L, et al. A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques. Med (New York, N.Y.). PMID 35132398 DOI: 10.1016/j.medj.2022.01.004 |
0.479 |
|
| 2022 |
Liu J, Chandrashekar A, Sellers D, Barrett J, Jacob-Dolan C, Lifton M, McMahan K, Sciacca M, VanWyk H, Wu C, Yu J, Collier AY, Barouch DH. Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron. Nature. PMID 35102312 DOI: 10.1038/s41586-022-04465-y |
0.6 |
|
| 2022 |
Liu J, Chandrashekar A, Sellers D, Barrett J, Lifton M, McMahan K, Sciacca M, VanWyk H, Wu C, Yu J, Collier AY, Barouch DH. Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant. Medrxiv : the Preprint Server For Health Sciences. PMID 35018387 DOI: 10.1101/2022.01.02.22268634 |
0.613 |
|
| 2022 |
Tostanoski LH, Chandrashekar A, Patel S, Yu J, Jacob-Dolan C, Chang A, Powers OC, Sellers D, Gardner S, Barrett J, Sanborn O, Stephenson KE, Ansel JL, Jaegle K, Seaman MS, et al. Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters. Npj Vaccines. 7: 2. PMID 35013325 DOI: 10.1038/s41541-021-00427-z |
0.588 |
|
| 2022 |
Nanishi E, Borriello F, O'Meara TR, McGrath ME, Saito Y, Haupt RE, Seo HS, van Haren SD, Cavazzoni CB, Brook B, Barman S, Chen J, Diray-Arce J, Doss-Gollin S, De Leon M, ... ... Yu J, et al. An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice. Science Translational Medicine. 14: eabj5305. PMID 34783582 DOI: 10.1126/scitranslmed.abj5305 |
0.52 |
|
| 2021 |
Rodrigues KA, Rodriguez-Aponte SA, Dalvie NC, Lee JH, Abraham W, Carnathan DG, Jimenez LE, Ngo JT, Chang JYH, Zhang Z, Yu J, Chang A, Nakao C, Goodwin B, Naranjo CA, et al. Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to alum potentiates humoral immunity against SARS-CoV-2. Science Advances. 7: eabj6538. PMID 34878851 DOI: 10.1126/sciadv.abj6538 |
0.494 |
|
| 2021 |
Nilles EJ, Siddiqui SM, Fischinger S, Bartsch YC, de St Aubin M, Zhou G, Gluck MJ, Berger S, Rhee J, Petersen E, Mormann B, Loesche M, Hu Y, Chen Z, Yu J, et al. Epidemiological and Immunological Features of Obesity and SARS-CoV-2. Viruses. 13. PMID 34835041 DOI: 10.3390/v13112235 |
0.454 |
|
| 2021 |
Gebre MS, Rauch S, Roth N, Yu J, Chandrashekar A, Mercado NB, He X, Liu J, McMahan K, Martinot A, Martinez DR, Giffin T, Hope D, Patel S, Sellers D, et al. Optimization of Non-Coding Regions for a Non-Modified mRNA COVID-19 Vaccine. Nature. PMID 34794169 DOI: 10.1038/s41586-021-04231-6 |
0.596 |
|
| 2021 |
Collier AY, Yu J, Mcmahan K, Liu J, Atyeo C, Ansel JL, Fricker ZP, Pavlakis M, Curry MP, Jacob-Dolan C, Patel H, Sellers D, Barrett J, Rowe M, Ahmad K, et al. COVID-19 mRNA Vaccine Immunogenicity in Immunosuppressed Individuals. The Journal of Infectious Diseases. PMID 34792136 DOI: 10.1093/infdis/jiab569 |
0.589 |
|
| 2021 |
Gebre MS, Rauch S, Roth N, Gergen J, Yu J, Liu X, Cole AC, Mueller SO, Petsch B, Barouch DH. mRNA Vaccines Induce Rapid Antibody Responses in Mice. Biorxiv : the Preprint Server For Biology. PMID 34751269 DOI: 10.1101/2021.11.01.466863 |
0.604 |
|
| 2021 |
Yu J, Collins ND, Mercado NB, McMahan K, Chandrashekar A, Liu J, Anioke T, Chang A, Giffin VM, Hope DL, Sellers D, Nampanya F, Gardner S, Barrett J, Wan H, et al. Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery Against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques. Journal of Virology. JVI0159921. PMID 34705557 DOI: 10.1128/JVI.01599-21 |
0.597 |
|
| 2021 |
Tostanoski LH, Yu J, Mercado NB, McMahan K, Jacob-Dolan C, Martinot AJ, Piedra-Mora C, Anioke T, Chang A, Giffin VM, Hope DL, Wan H, Bondzie EA, Mahrokhian SH, Wrijil LM, et al. Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern. Science Translational Medicine. eabj3789. PMID 34705477 DOI: 10.1126/scitranslmed.abj3789 |
0.601 |
|
| 2021 |
Collier AY, Brown CM, Mcmahan K, Yu J, Liu J, Jacob-Dolan C, Chandrashekar A, Tierney D, Ansel JL, Rowe M, Sellers D, Ahmad K, Aguayo R, Anioke T, Gardner S, et al. Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts. Medrxiv : the Preprint Server For Health Sciences. PMID 34704104 DOI: 10.1101/2021.10.18.21265113 |
0.597 |
|
| 2021 |
Collier AY, Yu J, McMahan K, Liu J, Chandrashekar A, Maron JS, Atyeo C, Martinez DR, Ansel JL, Aguayo R, Rowe M, Jacob-Dolan C, Sellers D, Barrett J, Ahmad K, et al. Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines. The New England Journal of Medicine. PMID 34648703 DOI: 10.1056/NEJMc2115596 |
0.573 |
|
| 2021 |
Roozendaal R, Solforosi L, Stieh DJ, Serroyen J, Straetemans R, Dari A, Boulton M, Wegmann F, Rosendahl Huber SK, van der Lubbe JEM, Hendriks J, Le Gars M, Dekking L, Czapska-Casey DN, Guimera N, ... ... Yu J, et al. SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques. Nature Communications. 12: 5877. PMID 34620860 DOI: 10.1038/s41467-021-26117-x |
0.614 |
|
| 2021 |
Langellotto F, Dellacherie MO, Yeager C, Ijaz H, Yu J, Cheng CA, Dimitrakakis N, Seiler BT, Gebre MS, Gilboa T, Johnson R, Storm N, Bardales S, Graveline A, White D, et al. A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 Antigens. Advanced Healthcare Materials. e2101370. PMID 34605223 DOI: 10.1002/adhm.202101370 |
0.618 |
|
| 2021 |
Chandrashekar A, Liu J, Yu J, McMahan K, Tostanoski LH, Jacob-Dolan C, Mercado NB, Anioke T, Chang A, Gardner S, Giffin VM, Hope DL, Nampanya F, Patel S, Sanborn O, et al. Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against re-infection with B.1.1.7 and B.1.351 variants. Science Translational Medicine. eabj2641. PMID 34546094 DOI: 10.1126/scitranslmed.abj2641 |
0.443 |
|
| 2021 |
Tostanoski LH, Gralinski LE, Martinez DR, Schaefer A, Mahrokhian SH, Li Z, Nampanya F, Wan H, Yu J, Chang A, Liu J, McMahan K, Ventura JD, Dinnon KH, Leist SR, et al. Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2. Journal of Virology. JVI0097421. PMID 34523968 DOI: 10.1128/JVI.00974-21 |
0.621 |
|
| 2021 |
Zeng C, Waheed AA, Li T, Yu J, Zheng YM, Yount JS, Wen H, Freed EO, Liu SL. SERINC proteins potentiate antiviral type I IFN production and proinflammatory signaling pathways. Science Signaling. 14: eabc7611. PMID 34520227 DOI: 10.1126/scisignal.abc7611 |
0.638 |
|
| 2021 |
Dalvie NC, Rodriguez-Aponte SA, Hartwell BL, Tostanoski LH, Biedermann AM, Crowell LE, Kaur K, Kumru OS, Carter L, Yu J, Chang A, McMahan K, Courant T, Lebas C, Lemnios AA, et al. Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34493582 DOI: 10.1073/pnas.2106845118 |
0.569 |
|
| 2021 |
Dalvie NC, Tostanoski LH, Rodriguez-Aponte SA, Kaur K, Bajoria S, Kumru OS, Martinot AJ, Chandrashekar A, McMahan K, Mercado NB, Yu J, Chang A, Giffin VM, Nampanya F, Patel S, et al. A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primates. Biorxiv : the Preprint Server For Biology. PMID 34282417 DOI: 10.1101/2021.07.13.452251 |
0.601 |
|
| 2021 |
Barouch DH, Stephenson KE, Sadoff J, Yu J, Chang A, Gebre M, McMahan K, Liu J, Chandrashekar A, Patel S, Gars ML, de Groot AM, Heerwegh D, Struyf F, Douoguih M, et al. Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19. Medrxiv : the Preprint Server For Health Sciences. PMID 34268527 DOI: 10.1101/2021.07.05.21259918 |
0.573 |
|
| 2021 |
Barouch DH, Stephenson KE, Sadoff J, Yu J, Chang A, Gebre M, McMahan K, Liu J, Chandrashekar A, Patel S, Le Gars M, de Groot AM, Heerwegh D, Struyf F, Douoguih M, et al. Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination. The New England Journal of Medicine. PMID 34260834 DOI: 10.1056/NEJMc2108829 |
0.574 |
|
| 2021 |
Yu J, Tostanoski LH, Mercado NB, McMahan K, Liu J, Jacob-Dolan C, Chandrashekar A, Atyeo C, Martinez DR, Anioke T, Bondzie EA, Chang A, Gardner S, Giffin VM, Hope DL, et al. Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques. Nature. PMID 34161961 DOI: 10.1038/s41586-021-03732-8 |
0.575 |
|
| 2021 |
Tostanoski LH, Gralinski LE, Martinez DR, Schaefer A, Mahrokhian SH, Li Z, Nampanya F, Wan H, Yu J, Chang A, Liu J, McMahan K, Dinnon KH, Leist SR, Baric RS, et al. Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 34159335 DOI: 10.1101/2021.06.14.448461 |
0.617 |
|
| 2021 |
He X, Chandrashekar A, Zahn R, Wegmann F, Yu J, Mercado NB, McMahan K, Martinot AJ, Piedra-Mora C, Beecy S, Ducat S, Chamanza R, Huber SR, van Heerden M, van der Fits L, et al. Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques. Cell. PMID 34133941 DOI: 10.1016/j.cell.2021.05.040 |
0.575 |
|
| 2021 |
Alter G, Yu J, Liu J, Chandrashekar A, Borducchi EN, Tostanoski LH, McMahan K, Jacob-Dolan C, Martinez DR, Chang A, Anioke T, Lifton M, Nkolola J, Stephenson KE, Atyeo C, et al. Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans. Nature. PMID 34107529 DOI: 10.1038/s41586-021-03681-2 |
0.581 |
|
| 2021 |
Nanishi E, Borriello F, O'Meara TR, McGrath ME, Saito Y, Haupt RE, Seo HS, van Haren SD, Brook B, Chen J, Diray-Arce J, Doss-Gollin S, Leon M, Chew K, Menon M, ... ... Yu J, et al. Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity. Biorxiv : the Preprint Server For Biology. PMID 34031655 DOI: 10.1101/2021.05.20.444848 |
0.575 |
|
| 2021 |
Collier AY, McMahan K, Yu J, Tostanoski LH, Aguayo R, Ansel J, Chandrashekar A, Patel S, Apraku Bondzie E, Sellers D, Barrett J, Sanborn O, Wan H, Chang A, Anioke T, et al. Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women. Jama. PMID 33983379 DOI: 10.1001/jama.2021.7563 |
0.52 |
|
| 2021 |
Vidal SJ, Collier AY, Yu J, McMahan K, Tostanoski LH, Ventura JD, Aid M, Peter L, Jacob-Dolan C, Anioke T, Chang A, Wan H, Aguayo R, Ngo D, Gerszten RE, et al. Correlates of Neutralization Against SARS-CoV-2 Variants of Concern by Early Pandemic Sera. Journal of Virology. PMID 33893169 DOI: 10.1128/JVI.00404-21 |
0.56 |
|
| 2021 |
Yu J, Li Z, He X, Gebre MS, Bondzie EA, Wan H, Jacob-Dolan C, Martinez DR, Nkolola JP, Baric RS, Barouch DH. Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays. Journal of Virology. PMID 33727331 DOI: 10.1128/JVI.00044-21 |
0.596 |
|
| 2021 |
Stephenson KE, Le Gars M, Sadoff J, de Groot AM, Heerwegh D, Truyers C, Atyeo C, Loos C, Chandrashekar A, McMahan K, Tostanoski LH, Yu J, Gebre MS, Jacob-Dolan C, Li Z, et al. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. Jama. PMID 33704352 DOI: 10.1001/jama.2021.3645 |
0.564 |
|
| 2021 |
Jacob-Dolan C, Feldman J, McMahan K, Yu J, Zahn R, Wegmann F, Schuitemaker H, Schmidt AG, Barouch DH. Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques Following SARS-CoV-2 Vaccination and Infection. Journal of Virology. PMID 33692201 DOI: 10.1128/JVI.00117-21 |
0.629 |
|
| 2021 |
Dalvie NC, Rodriguez-Aponte SA, Hartwell BL, Tostanoski LH, Biedermann AM, Crowell LE, Kaur K, Kumru O, Carter L, Yu J, Chang A, McMahan K, Courant T, Lebas C, Lemnios AA, et al. Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamsters. Biorxiv : the Preprint Server For Biology. PMID 33688647 DOI: 10.1101/2021.03.03.433558 |
0.58 |
|
| 2021 |
Yu KK, Fischinger S, Smith MT, Atyeo C, Cizmeci D, Wolf CR, Layton ED, Logue JK, Aguilar MS, Shuey K, Loos C, Yu J, Franko NM, Choi RY, Wald A, et al. Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2. Jci Insight. PMID 33621211 DOI: 10.1172/jci.insight.146242 |
0.467 |
|
| 2021 |
Bartsch YC, Fischinger S, Siddiqui SM, Chen Z, Yu J, Gebre M, Atyeo C, Gorman MJ, Zhu AL, Kang J, Burke JS, Slein M, Gluck MJ, Beger S, Hu Y, et al. Discrete SARS-CoV-2 antibody titers track with functional humoral stability. Nature Communications. 12: 1018. PMID 33589636 DOI: 10.1038/s41467-021-21336-8 |
0.567 |
|
| 2021 |
He X, Chandrashekar A, Zahn R, Wegmann F, Yu J, Mercado NB, McMahan K, Martinot AJ, Piedra-Mora C, Beecy S, Ducat S, Chamanza R, Huber SR, van der Fits L, Borducchi EN, et al. Low-Dose Ad26.COV2.S Protection Against SARS-CoV-2 Challenge in Rhesus Macaques. Biorxiv : the Preprint Server For Biology. PMID 33532782 DOI: 10.1101/2021.01.27.428380 |
0.577 |
|
| 2021 |
Mercado NB, Zahn R, Wegmann F, Loos C, Chandrashekar A, Yu J, Liu J, Peter L, McMahan K, Tostanoski LH, He X, Martinez DR, Rutten L, Bos R, van Manen D, et al. Publisher Correction: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature. PMID 33469218 DOI: 10.1038/s41586-020-03100-y |
0.559 |
|
| 2020 |
Martinot AJ, Blass E, Yu J, Aid M, Mahrokhian SH, Cohen SB, Plumlee CR, Larocca RA, Siddiqi N, Wakabayashi S, Gardner M, Audette R, Devorak A, Urdahl KB, Rubin EJ, et al. Protective efficacy of an attenuated Mtb ΔLprG vaccine in mice. Plos Pathogens. 16: e1009096. PMID 33315936 DOI: 10.1371/journal.ppat.1009096 |
0.573 |
|
| 2020 |
McMahan K, Yu J, Mercado NB, Loos C, Tostanoski LH, Chandrashekar A, Liu J, Peter L, Atyeo C, Zhu A, Bondzie EA, Dagotto G, Gebre MS, Jacob-Dolan C, Li Z, et al. Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature. PMID 33276369 DOI: 10.1038/s41586-020-03041-6 |
0.605 |
|
| 2020 |
Yu KKQ, Fischinger S, Smith MT, Atyeo C, Cizmeci D, Wolf CR, Layton ED, Logue JK, Aguilar MS, Shuey K, Loos C, Yu J, Franko N, Choi RY, Wald A, et al. T cell and antibody functional correlates of severe COVID-19. Medrxiv : the Preprint Server For Health Sciences. PMID 33269369 DOI: 10.1101/2020.11.25.20235150 |
0.498 |
|
| 2020 |
Zohar T, Loos C, Fischinger S, Atyeo C, Wang C, Slein MD, Burke J, Yu J, Feldman J, Hauser BM, Caradonna T, Schmidt AG, Cai Y, Streeck H, Ryan ET, et al. Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality. Cell. PMID 33207184 DOI: 10.1016/j.cell.2020.10.052 |
0.556 |
|
| 2020 |
Nilles EJ, Siddiqui SM, Fischinger S, Bartsch YC, de Saint Aubin M, Zhou G, Gluck M, Berger S, Rhee J, Petersen E, Mormann B, Loesche M, Chen Z, Yu J, Gebre M, et al. Epidemiological and immunological features of obesity and SARS-CoV-2. Medrxiv : the Preprint Server For Health Sciences. PMID 33200139 DOI: 10.1101/2020.11.11.20229724 |
0.406 |
|
| 2020 |
Iyer AS, Jones FK, Nodoushani A, Kelly M, Becker M, Slater D, Mills R, Teng E, Kamruzzaman M, Garcia-Beltran WF, Astudillo M, Yang D, Miller TE, Oliver E, Fischinger S, ... ... Yu J, et al. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Science Immunology. 5. PMID 33033172 DOI: 10.1126/sciimmunol.abe0367 |
0.485 |
|
| 2020 |
Tostanoski LH, Wegmann F, Martinot AJ, Loos C, McMahan K, Mercado NB, Yu J, Chan CN, Bondoc S, Starke CE, Nekorchuk M, Busman-Sahay K, Piedra-Mora C, Wrijil LM, Ducat S, et al. Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters. Nature Medicine. PMID 32884153 DOI: 10.1038/S41591-020-1070-6 |
0.594 |
|
| 2020 |
Dagotto G, Yu J, Barouch DH. Approaches and Challenges in SARS-CoV-2 Vaccine Development. Cell Host & Microbe. PMID 32798444 DOI: 10.1016/j.chom.2020.08.002 |
0.587 |
|
| 2020 |
Atyeo C, Fischinger S, Zohar T, Slein MD, Burke J, Loos C, McCulloch DJ, Newman KL, Wolf C, Yu J, Shuey K, Feldman J, Hauser BM, Caradonna T, Schmidt AG, et al. Distinct Early Serological Signatures Track with SARS-CoV-2 Survival. Immunity. PMID 32783920 DOI: 10.1016/J.Immuni.2020.07.020 |
0.531 |
|
| 2020 |
Iyer AS, Jones FK, Nodoushani A, Kelly M, Becker M, Slater D, Mills R, Teng E, Kamruzzaman M, Garcia-Beltran WF, Astudillo M, Yang D, Miller TE, Oliver E, Fischinger S, ... ... Yu J, et al. Dynamics and significance of the antibody response to SARS-CoV-2 infection. Medrxiv : the Preprint Server For Health Sciences. PMID 32743600 DOI: 10.1101/2020.07.18.20155374 |
0.495 |
|
| 2020 |
Mercado NB, Zahn R, Wegmann F, Loos C, Chandrashekar A, Yu J, Liu J, Peter L, McMahan K, Tostanoski LH, He X, Martinez DR, Rutten L, Bos R, van Manen D, et al. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature. PMID 32731257 DOI: 10.1038/S41586-020-2607-Z |
0.606 |
|
| 2020 |
Li A, Xue M, Attia Z, Yu J, Lu M, Shan C, Liang X, Gao TZ, Shi PY, Peeples ME, Boyaka PN, Liu SL, Li J. Vesicular stomatitis virus and DNA vaccines expressing Zika virus nonstructural protein 1 (NS1) induce substantial but not sterilizing protection against Zika virus infection. Journal of Virology. PMID 32554698 DOI: 10.1128/Jvi.00048-20 |
0.682 |
|
| 2020 |
Chandrashekar A, Liu J, Martinot AJ, McMahan K, Mercado NB, Peter L, Tostanoski LH, Yu J, Maliga Z, Nekorchuk M, Busman-Sahay K, Terry M, Wrijil LM, Ducat S, Martinez DR, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science (New York, N.Y.). PMID 32434946 DOI: 10.1126/Science.Abc4776 |
0.643 |
|
| 2020 |
Yu J, Tostanoski LH, Peter L, Mercado NB, McMahan K, Mahrokhian SH, Nkolola JP, Liu J, Li Z, Chandrashekar A, Martinez DR, Loos C, Atyeo C, Fischinger S, Burke JS, et al. DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Science (New York, N.Y.). PMID 32434945 DOI: 10.1126/Science.Abc6284 |
0.629 |
|
| 2019 |
Yu J, Murthy V, Liu SL. Relating GPI-Anchored Ly6 Proteins uPAR and CD59 to Viral Infection. Viruses. 11. PMID 31739586 DOI: 10.3390/V11111060 |
0.507 |
|
| 2019 |
Yu J, Liu SL. Emerging Role of LY6E in Virus-Host Interactions. Viruses. 11. PMID 31684192 DOI: 10.3390/V11111020 |
0.519 |
|
| 2019 |
Li M, Waheed AA, Yu J, Zeng C, Chen HY, Zheng YM, Feizpour A, Reinhard BM, Gummuluru S, Lin S, Freed EO, Liu SL. TIM-mediated inhibition of HIV-1 release is antagonized by Nef but potentiated by SERINC proteins. Proceedings of the National Academy of Sciences of the United States of America. PMID 30842281 DOI: 10.1073/Pnas.1819475116 |
0.73 |
|
| 2019 |
Yu J, Liang C, Liu SL. CD4-dependent Modulation of HIV-1 Entry by LY6E. Journal of Virology. PMID 30674630 DOI: 10.1128/Jvi.01866-18 |
0.579 |
|
| 2019 |
Lu W, Chen S, Yu J, Behrens R, Wiggins J, Sherer N, Liu SL, Xiong Y, Xiang SH, Wu L. The Polar Region of HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing gp120-gp41 Association. Journal of Virology. PMID 30651369 DOI: 10.1128/Jvi.02128-18 |
0.582 |
|
| 2018 |
Yu J, Liu SL. The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage. Viruses. 10. PMID 30087232 DOI: 10.3390/V10080413 |
0.544 |
|
| 2018 |
Li A, Yu J, Lu M, Ma Y, Attia Z, Shan C, Xue M, Liang X, Craig K, Makadiya N, He JJ, Jennings R, Shi PY, Peeples ME, Liu SL, et al. A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein. Nature Communications. 9: 3067. PMID 30076287 DOI: 10.1038/S41467-018-05276-4 |
0.673 |
|
| 2017 |
Yu J, Liang C, Liu SL. Interferon-inducible LY6E Protein Promotes HIV-1 Infection. The Journal of Biological Chemistry. PMID 28130445 DOI: 10.1074/Jbc.M116.755819 |
0.585 |
|
| 2017 |
Miller AD, De Las Heras M, Yu J, Zhang F, Liu SL, Vaughan AE, Vaughan TL, Rosadio R, Rocca S, Palmieri G, Goedert JJ, Fujimoto J, Wistuba II. Evidence against a role for jaagsiekte sheep retrovirus in human lung cancer. Retrovirology. 14: 3. PMID 28107820 DOI: 10.1186/S12977-017-0329-6 |
0.592 |
|
| 2017 |
Wang Y, Pan Q, Ding S, Wang Z, Yu J, Finzi A, Liu SL, Liang C. The V3-loop of HIV-1 Env determines viral susceptibility to IFITM3 impairment of viral infectivity. Journal of Virology. PMID 28100616 DOI: 10.1128/Jvi.02441-16 |
0.73 |
|
| 2016 |
Wilkins J, Zheng YM, Yu J, Liang C, Liu SL. Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV. Plos One. 11: e0156739. PMID 27257969 DOI: 10.1371/Journal.Pone.0156739 |
0.772 |
|
| 2015 |
Yu J, Li M, Wilkins J, Ding S, Swartz TH, Esposito AM, Zheng YM, Freed EO, Liang C, Chen BK, Liu SL. IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein. Cell Reports. PMID 26387945 DOI: 10.1016/J.Celrep.2015.08.055 |
0.747 |
|
| Show low-probability matches. |